EconPapers    
Economics at your fingertips  
 

Distinctive CD39+CD9+ lung interstitial macrophages suppress IL-23/Th17-mediated neutrophilic asthma by inhibiting NETosis

Seunghan Han, Bomin Kim, Do Young Hyeon, Daeun Jeong, Jaechan Ryu, Jae-Sung Nam, Yoon Ha Choi, Bo-Ram Kim, Sang Chul Park, Youn Wook Chung, Sung Jae Shin, June-Yong Lee, Jong Kyoung Kim, Jihye Park, Sei Won Lee, Tae-Bum Kim, Jae Hee Cheon, Hyung-Ju Cho, Chang-Hoon Kim, Joo-Heon Yoon (), Daehee Hwang () and Ji-Hwan Ryu ()
Additional contact information
Seunghan Han: Yonsei University College of Medicine
Bomin Kim: Yonsei University College of Medicine
Do Young Hyeon: Seoul National University
Daeun Jeong: Yonsei University College of Medicine
Jaechan Ryu: Microenvironment and Immunity Unit
Jae-Sung Nam: Yonsei University College of Medicine
Yoon Ha Choi: Pohang University of Science and Technology
Bo-Ram Kim: Yonsei University College of Medicine
Sang Chul Park: Hallym University College of Medicine
Youn Wook Chung: Yonsei University College of Medicine
Sung Jae Shin: Yonsei University College of Medicine
June-Yong Lee: Yonsei University College of Medicine
Jong Kyoung Kim: Pohang University of Science and Technology
Jihye Park: Yonsei University College of Medicine
Sei Won Lee: University of Ulsan College of Medicine
Tae-Bum Kim: University of Ulsan College of Medicine
Jae Hee Cheon: Yonsei University College of Medicine
Hyung-Ju Cho: Yonsei University College of Medicine
Chang-Hoon Kim: Yonsei University College of Medicine
Joo-Heon Yoon: Yonsei University College of Medicine
Daehee Hwang: Seoul National University
Ji-Hwan Ryu: Yonsei University College of Medicine

Nature Communications, 2024, vol. 15, issue 1, 1-18

Abstract: Abstract The IL-23-Th17 axis is responsible for neutrophilic inflammation in various inflammatory diseases. Here, we discover a potential pathway to inhibit neutrophilic asthma. In our neutrophil-dominant asthma (NDA) model, single-cell RNA-seq analysis identifies a subpopulation of CD39+CD9+ interstitial macrophages (IMs) suppressed by IL-23 in NDA conditions but increased by an IL-23 inhibitor αIL-23p19. Adoptively transferred CD39+CD9+ IMs suppress neutrophil extracellular trap formation (NETosis), a representative phenotype of NDA, and also Th17 cell activation and neutrophilic inflammation. CD39+CD9+ IMs first attach to neutrophils in a CD9-dependent manner, and then remove ATP near neutrophils that contribute to NETosis in a CD39-dependent manner. Transcriptomic data from asthmatic patients finally show decreased CD39+CD9+ IMs in severe asthma than mild/moderate asthma. Our results suggest that CD39+CD9+ IMs function as a potent negative regulator of neutrophilic inflammation by suppressing NETosis in the IL-23-Th17 axis and can thus serve as a potential therapeutic target for IL-23-Th17-mediated neutrophilic asthma.

Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-024-53038-2 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-53038-2

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-024-53038-2

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-53038-2